Literature DB >> 20575464

Comparison of two different screening methods for the KRAS mutation in colorectal cancer.

Tze-Kiong Er1, Ya-Sian Chang, Kun-Tu Yeh, Tien-Jye Chang, Jan-Gowth Chang.   

Abstract

BACKGROUND: To compare high resolution melting (HRM) and primer extension (PE) for mutation screening of KRAS codons 12 and 13.
METHODS: DNA samples were isolated from 60 colorectal cancer (CRC) patients. HRM and primer extension analyses were used for mutation screening of KRAS codons 12 and 13.
RESULTS: Both methods can detect KRAS mutations in a DNA mixture containing as little as 5% mutant DNA. The concordant rate between the two methods was 100%. HRM analysis is able to distinguish mutant from wild type, however, it is unable to detect the actual base change. PE analysis needs more procedures, is time-consuming and slightly more expensive but it is able to detect the precise mutation.
CONCLUSIONS: This study showed that HRM is a reliable screening method to identify mutations in the KRAS gene, and the PE can be used as a diagnostic method to accurately pinpoint the nature of mutations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20575464

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  5 in total

1.  KRAS Testing: A Tool for the Implementation of Personalized Medicine.

Authors:  Rodney E Shackelford; Nicholas A Whitling; Patricia McNab; Shanker Japa; Domenico Coppola
Journal:  Genes Cancer       Date:  2012-07

2.  High-resolution melting for detecting KRAS mutations in colorectal cancer.

Authors:  Raelson Rodrigues Miranda; Tiago Donizetti Silva; Nora Manoukian Forones
Journal:  Biomed Rep       Date:  2019-11-07

3.  Computational analysis of KRAS mutations: implications for different effects on the KRAS p.G12D and p.G13D mutations.

Authors:  Chih-Chieh Chen; Tze-Kiong Er; Yen-Yi Liu; Jenn-Kang Hwang; Maria Jesus Barrio; Maximiliano Rodrigo; Enrique Garcia-Toro; Marta Herreros-Villanueva
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

4.  KRAS mutation detection in paired frozen and Formalin-Fixed Paraffin-Embedded (FFPE) colorectal cancer tissues.

Authors:  Jérome Solassol; Jeanne Ramos; Evelyne Crapez; Majda Saifi; Alain Mangé; Evelyne Vianès; Pierre-Jean Lamy; Valérie Costes; Thierry Maudelonde
Journal:  Int J Mol Sci       Date:  2011-05-17       Impact factor: 5.923

Review 5.  New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

Authors:  Giuseppe Bronte; Nicola Silvestris; Marta Castiglia; Antonio Galvano; Francesco Passiglia; Giovanni Sortino; Giuseppe Cicero; Christian Rolfo; Marc Peeters; Viviana Bazan; Daniele Fanale; Antonio Giordano; Antonio Russo
Journal:  Oncotarget       Date:  2015-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.